Screener
Cytokinetics CYTK Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's net income?
- Cytokinetics (CYTK) reported net income of -$198.76M in Q2 2026.
- How has Cytokinetics's net income changed year-over-year?
- Cytokinetics's net income decreased by 47.9% year-over-year, from -$134.37M to -$198.76M.
- What is the long-term trend for Cytokinetics's net income?
- Over 4 years (2021 to 2025), Cytokinetics's net income has grown at a 38.2% compound annual growth rate (CAGR), from -$215.31M to -$784.96M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Cytokinetics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude